Vanguard Group
MRKR icon

Vanguard Group’s Marker Therapeutics MRKR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$421K Hold
275,345
﹤0.01% 3959
2025
Q1
$339K Buy
275,345
+32,223
+13% +$39.6K ﹤0.01% 3971
2024
Q4
$756K Hold
243,122
﹤0.01% 3838
2024
Q3
$686K Buy
243,122
+4,800
+2% +$13.5K ﹤0.01% 3890
2024
Q2
$1.29M Buy
238,322
+5,091
+2% +$27.6K ﹤0.01% 3707
2024
Q1
$1M Buy
233,231
+8,174
+4% +$35.1K ﹤0.01% 3811
2023
Q4
$1.24M Buy
225,057
+3,975
+2% +$21.9K ﹤0.01% 3759
2023
Q3
$1M Buy
221,082
+55,483
+34% +$252K ﹤0.01% 3826
2023
Q2
$513K Sell
165,599
-1,282
-0.8% -$3.97K ﹤0.01% 4114
2023
Q1
$118K Sell
166,881
-1,600,972
-91% -$1.14M ﹤0.01% 4387
2022
Q4
$470K Buy
1,767,853
+1,562
+0.1% +$415 ﹤0.01% 4114
2022
Q3
$651K Sell
1,766,291
-541,003
-23% -$199K ﹤0.01% 4147
2022
Q2
$761K Hold
2,307,294
﹤0.01% 4174
2022
Q1
$1.02M Sell
2,307,294
-380,777
-14% -$168K ﹤0.01% 4204
2021
Q4
$2.55M Sell
2,688,071
-3,639
-0.1% -$3.46K ﹤0.01% 3952
2021
Q3
$4.55M Hold
2,691,710
﹤0.01% 3723
2021
Q2
$7.51M Buy
2,691,710
+142,225
+6% +$397K ﹤0.01% 3365
2021
Q1
$5.71M Buy
2,549,485
+1,157,297
+83% +$2.59M ﹤0.01% 3459
2020
Q4
$2.02M Sell
1,392,188
-65,181
-4% -$94.5K ﹤0.01% 3656
2020
Q3
$2.19M Sell
1,457,369
-76,147
-5% -$114K ﹤0.01% 3458
2020
Q2
$3.17M Sell
1,533,516
-8,018
-0.5% -$16.6K ﹤0.01% 3288
2020
Q1
$2.93M Sell
1,541,534
-5,272
-0.3% -$10K ﹤0.01% 3188
2019
Q4
$4.46M Sell
1,546,806
-5,814
-0.4% -$16.7K ﹤0.01% 3208
2019
Q3
$7.93M Buy
1,552,620
+128,750
+9% +$658K ﹤0.01% 2934
2019
Q2
$11.3M Buy
1,423,870
+198,467
+16% +$1.57M ﹤0.01% 2791
2019
Q1
$8.09M Buy
1,225,403
+270,166
+28% +$1.78M ﹤0.01% 2936
2018
Q4
$5.3M Buy
955,237
+579,326
+154% +$3.21M ﹤0.01% 3067
2018
Q3
$3.4M Buy
375,911
+188,212
+100% +$1.7M ﹤0.01% 3361
2018
Q2
$1.77M Buy
187,699
+50,797
+37% +$479K ﹤0.01% 3538
2018
Q1
$455K Buy
136,902
+46,549
+52% +$155K ﹤0.01% 3804
2017
Q4
$356K Buy
90,353
+8,500
+10% +$33.5K ﹤0.01% 3824
2017
Q3
$246K Buy
+81,853
New +$246K ﹤0.01% 3878